(KYMR) – Analyst Ratings
-
Oppenheimer Starts Kymera Therapeutics (KYMR) at Outperform
-
Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KYMR Stock Lookup